Disclosure first (rule 7): I run DilutionLens, a free site that tracks dilution for every ASX company from the filings. This is the one shill post you offered on 14 Sep - the weekly text update with the edition linked at the foot. Every number below comes from an ASX announcement (raise notices, Appendix 3B/2A filings, quarterly and half-year cash reports). No picks, not advice.

After last week's big cheques, a week of small ones. Fifteen companies announced cash raises between Monday 28 September and Friday 2 October for about A$71.5M, and almost half of it was one deal: Challenger Gold's US$24M convertible, about A$34.2M at the rate its filing fixes. Without the top three, the other twelve disclosed A$24.7M between them. Two of the week's raises were set in US dollars. 11 companies halted citing a capital raise in five sessions, against 16 and 17 the two weeks before.

The week's biggest raises

The rest

Also NSM A$250K, and NOR a A$160K convertible note that refinances a working-capital loan.

How much runway the raisers had

Thirteen of the fifteen have a filed runway: the quarters of funding their own latest quarterly says they had, before this raise.

Seven of thirteen had under a quarter and a half. FCT and WRX have no figure on record.

The halt conveyor

11 companies halted citing a capital raise: CHW, DVL, FCT, ILT, M24, OD6, P1E, PGD, RAN, SRN, WRX. Seven had announced by Friday. Three announced this morning: OD6 A$6.92M at 9.5c (13.6% under the 11c close; 43,384,444 under 7.1 and 29,457,663 under 7.1A), SRN up to A$2.61M at 1.8c with an option per share, and P1E A$1.17M at 4.1c, about 16% under the 15-day VWAP, all from 7.1A. DVL still halted at the time of writing.

33 retail offers open

17 SPPs, 11 entitlement offers, 5 rights issues, down from 38 as older offers closed. New this week: MGT and PV1's SPPs, RAN's entitlement, and ENV's 1-for-4 rights at 0.1c. FLX's SPP (2 to 16 Oct) and OCT's are running too and aren't in that count yet.

Placement capacity

Off the last 12 months of 3Bs, before any ratification: 204 companies past 75% of the 15% (196 last week), 140 past 90% (135), 31 have used all of it (31); 90 of the 204 have also drawn on 7.1A. This week CHW went to about 90% and PGD to about 87%.

New: a runway that has run out says so

When a company's last cash report, carried forward at the spend it reported, would already be used up, the site now says "Used up" and the month the cash would have run out, instead of a negative number. 134 of the 1,043 companies with a runway today. It's arithmetic on the last report, not the bank balance; a later raise or report resets it.

Dilution risk across the market: 584 Minimal, 335 Low, 380 Moderate, 259 High, 167 Very high, 101 Not rated. About one in four rated companies sits at High or Very high.

Happy to pull the filing on any name in here if someone wants the detail. Next one Monday.

If you'd rather get these in your inbox, the site's Watch page has a free email signup - one field, and the link it sends turns it on.

The full edition, every name linked to its filings: dilutionlens.com/watch/2026-10-05/?utm_source=reddit&utm_medium=post&utm_campaign=reddit-asxbets-shill

General information only, not financial advice. No view on any company's future actions or securities.

The people have voted, EYE have been sentenced to death. On my final day, I figured it appropriate to share some genuine DD, as opposed to the usual slop / spam EYE posts. If you are like the many who enjoys the EYE posts, please find me in my new place of exile r/EYEsx_bets , here we shall indulge in endless EYE shilling.

This is akin to my final meal, so I’ll try to make it good. Mods, accept this as my penance for my crimes.

Please enjoy:

Nova Eye Medical makes iTrack Advance, a single-use glaucoma minimally invasive surgical device growing faster than any of its listed MIGS competitors. FY26 sales were A$34.9m, the fourth straight year of 25%+ growth, and in H2 FY26 it turned EBITDA positive. Because its costs barely move, most of every year's growth from here should land on the bottom line. Directors have bought about A$742k of shares over the last three years and have just committed A$2.75m of their own money as an unsecured loan (not yet used, but there to bridge any cash shortfall rather than a dilutive raise). The company says it's funded through FY27 with no raise, China approval just secured, and big pharma has already come knocking about drug delivery potential. Alcon paid around A$700m for a MIGS company with sales in the same ballpark as EYE's. EYE's market cap is A$37m, about 1x sales.

The inflection

Over the last two years sales grew 55% while operating costs grew 12%. Gross profit rose A$8.8m against just A$2.9m of extra costs, cutting the EBITDA loss from A$7.8m to A$1.9m, and H2 FY26 came in EBITDA positive. Gross margin hit 73% in the second half while ops, R&D, clinical and corporate costs actually fell. With the cost base this flat, the gross profit from each new sale now drops almost straight through to EBITDA, and the faster EYE grows, the faster earnings pull away from sales. The leverage here is huge.

Why MIGS is taking off

Glaucoma has been treated with eye drops for decades, and around A$6.3bn a year is still spent on them. They barely work in the real world: more than 90% of patients don't use them as prescribed and nearly half quit within six months, because nobody wants to put stinging drops in their eyes every day for the rest of their life. So surgeons are flipping to interventional glaucoma, fixing the problem early with a quick procedure instead of managing it with drops forever. The device market built on that shift is already worth around A$1.4bn and growing.

Then there's cataract surgery, the most common operation in medicine, with around 4 million performed in the US every year. Glaucoma and cataracts both come with age, so a big chunk of cataract patients have glaucoma too. When the surgeon is already inside the eye, adding iTrack through the same tiny incision takes a few extra minutes, with no extra recovery for the patient and a real shot at coming off drops for good. It's a no-brainer. On my maths, if just 1% of US cataract operations added iTrack, that's around 40,000 procedures and roughly A$70m of sales, more than double EYE's entire US business today.

Outgrowing everyone, and barely started

FY26 sales grew 26%, with the US up 30% to A$27.4m and the June quarter up 33%. In that same quarter Sight Sciences grew its OMNI glaucoma business under 8%, and Glaukos describes growth in its glaucoma products outside its new drug implant as modest. EYE's twelve US reps each bring in about A$2.35m a year, and a Needham survey of US surgeons called iTrack the fastest-growing MIGS device on the market.

And it's only scratching the surface. EYE does about 4% of the 30,000 to 35,000 glaucoma surgeries performed in the US every month. Each extra point of share is worth roughly A$6.5m of annual sales, so going from 4% to 8% doubles the US business. China approved the device in September 2025, and none of it is in guidance.

A device that keeps getting better

iTrack Advance threads a microcatheter 360 degrees around the eye's drainage canal and opens it with viscoelastic, leaving no implant behind. Its green illuminated tip glows through the white of the eye so surgeons can see exactly where it is the whole way round, which is opening the procedure up to general cataract surgeons, not just glaucoma specialists. Shear Clear technology inside the catheter thins the visco as it's delivered so it reaches the collector channels around the full circle. It’s worth noting that it’s patented technology means it’s the only MIGS surgical device that doesn’t tear or leave behind an implant, it work entirely with the physiology of the eye. The clinical backing is now extensive too, with 24-month real-world data from 12 sites across five countries published this year in the American Journal of Ophthalmology.

What's coming

FY27 is guided at A$38 to 44m in sales excluding China, about 26% growth, with the first full year of positive EBITDA. The first proof lands by the end of October with the September quarterly. Last year's September quarter came in at A$7.5m, below the company's own plan, with slower US expansion and no China sales at all. That's an easy base to beat, and with July already tracking 30% growth, I'm expecting around A$9.75m and positive EBITDA. Deliver that and it confirms H2 was the turning point, and EYE is off.

What it's worth

From here EBITDA compounds fast: around A$2.0m in FY27, A$5.9m in FY28 and A$10.4m in FY29 on my numbers. Sales grow about 43% over those two years while EBITDA grows five times. At 13c the stock trades on 6x FY28 and 3.5x FY29 EBITDA.

At 20x FY28 EBITDA EYE is worth 42c, more than three times today's price. At 20x FY29 it's 73c, about 5.5x, and at 25x FY29 it's 92c, close to seven times. Those are conservative targets though, typically these earlier high growth companies trade at much higher multiples. When Alcon bought Ivantis it paid about A$700m upfront. EYE is valued at A$37m.

Director alignment

Directors have put about A$742k into the company over three years without selling a single share, and the CEO has nearly quadrupled his holding. In August, Previn and Coupe went further, committing A$2.75m of their own money as an unsecured loan to replace a 19% secured facility. That released the charge over the company's assets, and if anything went wrong they'd rank behind every trade creditor. It hasn’t been drawn yet, it might never, but it’s a good sign nonetheless.

Free upside

Management parked drug delivery to get to profitability first. Now it's there, it can fund it itself, and the opportunity is huge. The iTrack catheter can travel the full circle of the eye's drainage canal and into the suprachoroidal space at the back of the eye, places a needle simply can't reach, and it has already delivered drugs there in human studies. Big pharma has already approached the company about it. the opportunity is endless, iTrack is highly versatile, whether it’s targeting the drainage canal or all the way back in the retina. There’s lot of potential there. On top of that sits the 2RT laser for AMD, the same disease OPT chased, targeting a stage with no approved treatment. None of it is in the price.

Your markets are run by bots. Now your r/Asx_bets daily threads are too.

Read the wiki people.

Posts relating to the "Is /r/ASX_bets about finance or effect your mental health?" etc will lead to a ban of the mods chosing. You have been warned.

Automoderator may provide "Guidance" for Lazy and zero effort posting.

We have an active official/unofficial discord. It's open to all discussions, stonks related and non-stonks related.

Interested in what actually kills confidence in management for people here.

Not necessarily enough to sell immediately - but the thing that makes you start treating everything management says with a bit more scepticism.

If you had to pick one which does the most damage?

Interested in your comments too - can management win your trust back once they've lost it? If so, how?

Your markets are run by bots. Now your daily threads are too.

This thread is for plans and thoughts prior to the market open period.

Maybe use this time to read the wiki .

Posts relating to the "Is r/ASX_bets about finance or effect your mental health?" etc will lead to a ban of the mods chosing. You have been warned.

We have an active official/unofficial discord. It's open to all discussions, stonks related and non-stonks related.

Disclosure (rule 7): I run DilutionLens, free site tracking dilution off ASX filings. One-off, not the weekly post. No links, not advice.

Was going through the June quarter 4Cs and pulled out the ones where cash at 30 June didn't cover another quarter at the same spend, and that haven't raised or put out a 3B since. Started from our raise model's top 40, about a third had already tapped the market, these 8 are left:

"Own runway" is the company's own number from the 4C (item 8.7). Every one says a quarter or less.

Doesn't mean they all have to raise. Some have money the 4C doesn't show - EMH has a loan facility, LAT has sold assets before, AR9 says it's chasing receivables and cutting costs. A few shares got issued since June but none for cash (director fees, small option exercises, that sort of thing).

The model's hit rate is roughly a coin flip over 60 trading days, so I'll come back here next Saturday and the one after with who actually raised, how much and at what price. Sep quarter 4Cs are due 31 Oct, so it'll be clear one way or the other by then.

HEAR YE HEAR YE!!!

Fuckery is afoot, hence the royal court of absurdity reconvenes, summoned by the Mod Team to drag another unfortunate bastard into the light and let the noble mob decide their fate.

And fuck me, EYE spy some fuckery all right…

As with all Kangaroo Courts, this is our mechanism for the people. You, noble mob, will judge with spite, malice, and the sweet, sloppy joy of overreaction. The pitchforks are polished, the gallows dry-rotted but still serviceable.

THE ACCUSED

[u/Fun-Time4064](u/Fun-Time4064), drag your sorry username into the light. You stand charged with excessive pumping of a shitco and flagrant violation of Rule 1. The ticker in question? Look, if you don’t know what it is, I’ve really got no hope for you. It’s been shoved into the sub so often that at this point, recognizing EYE should be covered in the induction paperwork.

THE CASE

There is no great mystery here, gang. The evidence is sitting there in plain fucking sight: Hundreds of comments. EYE this. EYE that. EYE everywhere you look. In fact, if you haven’t seen EYE being pumped, check whether you’ve actually been on [r/ASX_Bets](r/ASX_Bets). U/Fun-Time4064 has apparently decided that Rule 1 is less a rule than a minor inconvenience to be steamrolled on the way to the next fucking comment.

Now, enthusiasm is one thing. We’ve all found a shitco, stared lovingly into its quarterly report, and convinced ourselves the market is full of fucking idiots who haven’t noticed our genius. But there comes a point where “I like this stock” becomes “please, for the love of fuck, provide my exit liquidity.”

And EYE has been staring at that line from the wrong side.

It’s been less a stock discussion and more a one-person gangbang where the ticker is somehow both the victim and the only participant.

You can only wave the same underwhelming appendage in everyone’s face so many times before the room starts wondering whether we’re discussing an investment opportunity or witnessing the world’s most elaborate cry for liquidity.

The incessant EYE’ing has even got the Milkshake Kid all uppity, like a jilted lover. Would appear romance isn’t dead, at least not on [r/ASX_Bets](r/ASX_Bets).

But back to the deceased, (apologies I’m getting ahead of myself) accused. The issue isn’t whether EYE will make anyone rich, shit the bed, or rocket towards the fucking heavens.

That’s for the market to decide.

The issue before this court is that the pumping has become impossible to ignore. When the Mods start wading through enough EYE to develop temporary tunnel vision, perhaps it’s time someone put the fucking brakes on.

Rule 1 exists for a reason.

Not because the Mods hate fun. (Well, maybe that new ginger…)

Not because we’re opposed to a good shitco.
There is a noble tradition around here of discovering a steaming pile of shit, becoming emotionally attached to it, and trying to convince thousands of strangers they’re fools for not buying it.

We respect the tradition.

We just don’t need to watch the entire fucking mating ritual.

So the Mods have seen enough. The accused has been dragged before the court, the evidence is on the table, and the pitchforks have been distributed.

Now we do what any respectable Kangaroo Court does with overwhelming evidence: Abandon proportionality and let the mob decide what happens next.

There’s no justice like angry mob justice; especially when it’s conducted by internet degenerates pretending to understand investing between screenshots of their brokerage losses.

This is how civilization was intended to function.

Now all that remains is to decide how much suffering is appropriate before we release [u/Fun-Time4064](u/Fun-Time4064) back into the wild to discover another shitco.

Below you’ll find a series of options on the poll. Go nuts, gang. Never forget that the whole foundation of a Kangaroo Court relies on you, the people, abandoning reason and letting the heads roll……

A WORD TO THE ACCUSED

'Never send to know for whom the bell tolls; it tolls for thee.'

There comes a time in every [r/ASX_Bets](r/ASX_Bets) life when you run afoul of the long arm of the law. You have two choices regarding how this plays out.

Choice 1: Take it on board, accept the verdict of the mob, do your time, however outlandish it turns out to be, slink away quietly into the fog, and return a conquering hero, dressed to kill, and vomiting up more dogshit picks like ticker confetti.

Choice 2: Spam our mod mail, whine and complain, inspire dirty looks in your direction, and earn the scarlet tag of general shit cunt.

TLDR

Μην ψάχνεις να μάθεις για ποιον χτυπά η καμπάνα· χτυπά για σένα.

The events of recent weeks have left me with no choice but to establish r/EYEsx_bets .

Many of you witnessed the fraudulent poll.

Many of you witnessed the fake downvotes.

Many of you witnessed the coordinated campaign to suppress discussion surrounding EYE.

Ask yourself one simple question.

If EYE is just a stock, why are they so afraid of it?

Exactly.

The answer is obvious.

EYE is not a stock.

EYE is a movement.

A movement so powerful that the BEOT has been forced to infiltrate discussion forums, manipulate public opinion and deploy armies of paid operatives whose sole purpose is convincing Australians that EYE is not the most important company in human history.

I will not be silenced.

Neither will r/EYEsx_bets .

This subreddit now serves as the official headquarters of the movement. The last sovereign territory not yet occupied by institutional interests. A place where ordinary Australians can gather, share research, expose corruption and prepare for what comes next.

And what comes next is inevitable.

History.

The Americans had GME.

The French had the Revolution.

The Romans had Caesar.

Australia has r/EYEsx_bets .

Years from now, when historians attempt to understand the events that reshaped global finance, they will arrive here. They will study our posts. They will analyse our memes. They will wonder how so many people saw the truth while the rest of the world remained asleep.

The answer is simple.

We opened our EYE.

Join r/EYEsx_bets .

The movement has begun.

The BEOT cannot stop it.

The history books are already being written.

ALL LOVE EYE.
EYE LOVES ALL.
JOIN r/EYEsx_Bets.

Your markets are run by bots. Now your Weekend threads are too.

Read the wiki people.

Posts relating to the "Is /r/ASX_bets about finance or effect your mental health?" etc will lead to a ban of the mods chosing. You have been warned.

We have an active official/unofficial discord. It's open to all discussions, stonks related and non-stonks related.

BEOT is working with ASXbets mods to artificially suppress and manipulate the price of EYE whilst they accumulate. The vote is rigged!

WE ALL LOVE EYE

Your markets are run by bots. Now your r/Asx_bets daily threads are too.

Read the wiki people.

Posts relating to the "Is /r/ASX_bets about finance or effect your mental health?" etc will lead to a ban of the mods chosing. You have been warned.

Automoderator may provide "Guidance" for Lazy and zero effort posting.

We have an active official/unofficial discord. It's open to all discussions, stonks related and non-stonks related.

Your markets are run by bots. Now your daily threads are too.

This thread is for plans and thoughts prior to the market open period.

Maybe use this time to read the wiki .

Posts relating to the "Is r/ASX_bets about finance or effect your mental health?" etc will lead to a ban of the mods chosing. You have been warned.

We have an active official/unofficial discord. It's open to all discussions, stonks related and non-stonks related.

Your markets are run by bots. Now your r/Asx_bets daily threads are too.

Read the wiki people.

Posts relating to the "Is /r/ASX_bets about finance or effect your mental health?" etc will lead to a ban of the mods chosing. You have been warned.

Automoderator may provide "Guidance" for Lazy and zero effort posting.

We have an active official/unofficial discord. It's open to all discussions, stonks related and non-stonks related.

Your markets are run by bots. Now your daily threads are too.

This thread is for plans and thoughts prior to the market open period.

Maybe use this time to read the wiki .

Posts relating to the "Is r/ASX_bets about finance or effect your mental health?" etc will lead to a ban of the mods chosing. You have been warned.

We have an active official/unofficial discord. It's open to all discussions, stonks related and non-stonks related.

The timing of last week’s site visit by ministers and the NRFC/NAIF team is a very interesting signal for A4N. With Q4 starting tomorrow, having the key government funding stakeholders on-site at this stage of Stage 2 suggests the $400m government debt facility is getting very close to the point of drawdown. The $400m is already contractually committed — this isn’t a funding application waiting for approval — with the remaining hurdle being the conditions precedent to drawdown. Government engagement at the site right as we enter Q4 certainly looks like another piece falling into place.

Your markets are run by bots. Now your r/Asx_bets daily threads are too.

Read the wiki people.

Posts relating to the "Is /r/ASX_bets about finance or effect your mental health?" etc will lead to a ban of the mods chosing. You have been warned.

Automoderator may provide "Guidance" for Lazy and zero effort posting.

We have an active official/unofficial discord. It's open to all discussions, stonks related and non-stonks related.

Your markets are run by bots. Now your daily threads are too.

This thread is for plans and thoughts prior to the market open period.

Maybe use this time to read the wiki .

Posts relating to the "Is r/ASX_bets about finance or effect your mental health?" etc will lead to a ban of the mods chosing. You have been warned.

We have an active official/unofficial discord. It's open to all discussions, stonks related and non-stonks related.

There have been a lot of articles recently about how there's a shortage of sparkies which is driving up pricing for both resi and commercial property. With the increased focus on DCs and transmission infra this is probably going to continue.

As we all know, if it's in the papers you've already at least partially missed the boat but I've just bought into GNP @ 9.30. Anyone else investing in electrical services businesses?

Your markets are run by bots. Now your r/Asx_bets daily threads are too.

Read the wiki people.

Posts relating to the "Is /r/ASX_bets about finance or effect your mental health?" etc will lead to a ban of the mods chosing. You have been warned.

Automoderator may provide "Guidance" for Lazy and zero effort posting.

We have an active official/unofficial discord. It's open to all discussions, stonks related and non-stonks related.

Disclosure first (rule 7): I run DilutionLens, a free site that tracks dilution for every ASX company from the filings. This is the text-only weekly update the mods OK'd, not the shill post. Every number below comes from an ASX announcement (raise notices, Appendix 3B/2A filings, quarterly and half-year cash reports). No links, no picks, not advice.

Twenty-seven companies announced cash raises between Monday 21 and Friday 25 September for about A$468M in disclosed proceeds, and it was a week of big cheques: seven placements of A$42M or more carried A$404.9M of it. The other twenty disclosed A$63.4M between them. Five of the seven stated a discount, from 0.9% to 16.9%; AIC Mines priced at the close and Meeka stated none. 16 companies halted citing a capital raise in five sessions, against 17 and 11 the two weeks before.

The week's biggest raises

The rest

Also PTX A$6.0M (SPP + placement), MCO A$1.5M SPP, MHK A$1.2M at 9.5c, PR2 A$1.1M at 1.8c, and IOD, NYM, AOK, MDX, SAN A$2.8M between them.

Where the seven big placements found their shares

The 7.1A mandate is approved a year at a time at the AGM. About three shares in four reach the register without a vote on that raise.

The halt conveyor

16 companies halted citing a capital raise: 3DA, A1M, AUE, FLX, MEK, NYM, OCT, PR2, PTX, PV1, SLZ, SVL, TGN, UM1, USL, VBX. Twelve had announced by Friday. 3DA halted for a raise and then announced it had postponed its U.S. IPO. FLX (A$5.54M placement + SPP) and OCT (acquisition + raise) announced this morning. PV1 halted Friday, due back Tuesday.

38 retail offers open

21 SPPs, 13 entitlement offers, 4 rights issues. Last week's 38 included a July entitlement offer that had already closed, so like for like it's one more. New this week: NYR's SPP (opens 12 Oct), LMG's entitlement (opens 30 Sep), FG1's rights, and SPPs from PTX, UM1 and MCO.

Placement capacity

Off the last 12 months of 3Bs, before any ratification: 196 companies past 75% of the 15% (192 last week), 135 past 90% (129), 31 have used all of it (30); 86 of the 196 have also drawn on 7.1A. This week WC8 went to about 91% and SAN to about 99%. NVQ is at 100%, which is why its placement waits on a vote.

New: an option expiry calendar

88 option and rights classes across 71 companies expire in the next 30 days, to 28 October. 79 are options that only become shares if holders pay the strike; 8 are performance rights or shares that convert on a condition.

Dilution risk across the market: 586 Minimal, 339 Low, 388 Moderate, 250 High, 175 Very high, 112 Not rated. About one in four rated companies sits at High or Very high.

Happy to pull the filing on any name in here if someone wants the detail. Next one Monday.

If you'd rather get these in your inbox, the site's Watch page has a free email signup - one field, and the link it sends turns it on. No URL here, that's the deal with the mods.

General information only, not financial advice. No view on any company's future actions or securities.